Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:insulin
gptkb:insulin_degludec |
| gptkbp:approvedBy |
gptkb:European_Union
gptkb:India gptkb:Japan |
| gptkbp:ATCCode |
A10AD06
|
| gptkbp:brand |
insulin degludec/insulin aspart combination
|
| gptkbp:form |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ryzodeg
|
| gptkbp:indication |
gptkb:diabetes_mellitus
|
| gptkbp:manufacturer |
gptkb:Novo_Nordisk
|
| gptkbp:mechanismOfAction |
long-acting and rapid-acting insulin combination
|
| gptkbp:powers |
70% insulin degludec, 30% insulin aspart
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:bfsParent |
gptkb:insulin
gptkb:Purdue_Pharma |
| gptkbp:bfsLayer |
6
|